Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CYNK-001 |
Trade Name | |
Synonyms | Taniraleucel|CYNK001|CYNK 001 |
Drug Descriptions |
CYNK-001 (taniraleucel) consists of allogeneic CD56+/CD3- natural killer cells expanded from CD34-positive placental stem cells, which may induce cytotoxicity against tumor cells and potentially demonstrates anti-tumor activity (Neuro-Oncology, Vol. 21, Issue Suppl_6, Nov. 2019, Page vi85, EXTH-16). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C173877 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CYNK-001 | CYNK-001 | 0 | 3 |